Search research articles
Contact Us
Filters
Showing results (1-10 of 118) with videos related to
Page
of 12
Sort By:
Seminars in Liver Disease
|
May 2, 2019
Clinical Trials in PBC Going Forward
Christophe Corpechot
Clinics in Liver Disease
|
October 21, 2022
Noninvasive Evaluation of Fibrosis and Portal Hypertension in Primary Biliary Cholangitis
Christophe Corpechot
Clinics and Research in Hepatology and Gastroenterology
|
November 13, 2012
Primary biliary cirrhosis and bile acids
Christophe Corpechot
Seminars in Liver Disease
|
February 13, 2016
Primary Biliary Cirrhosis Beyond Ursodeoxycholic Acid
Christophe Corpechot
Clinics in Liver Disease
|
November 24, 2015
Utility of Noninvasive Markers of Fibrosis in Cholestatic Liver Diseases
Christophe Corpechot
Clinics and Research in Hepatology and Gastroenterology
|
April 27, 2024
PPAR agonists in PBC: Where do we go from here? Or how to choose between the new and the old
Atsushi Tanaka, Christophe Corpechot
JHEP Reports : Innovation in Hepatology
|
February 11, 2020
New treatments/targets for primary biliary cholangitis
Christophe Corpechot, Raoul Poupon, Olivier Chazouillères
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 7, 2020
Definition and Management of Patients With Primary Biliary Cholangitis and an Incomplete Response to Therapy
Aldo J Montano-Loza, Christophe Corpechot
Journal of Hepatology
|
June 28, 2011
Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome
Christophe Corpechot, Olivier Chazouillères, Raoul Poupon
La Revue Du Praticien
|
February 11, 2022
[Primary biliary cholangitis]
Pierre-Antoine Soret, Olivier Chazouillères, Christophe Corpechot
Page
of 12
Search research articles
Search
Showing results (1-10 of 118) with videos related to
Sort By:
Page
of 12
Seminars in Liver Disease
|
May 2, 2019
Clinical Trials in PBC Going Forward
Christophe Corpechot
Clinics in Liver Disease
|
October 21, 2022
Noninvasive Evaluation of Fibrosis and Portal Hypertension in Primary Biliary Cholangitis
Christophe Corpechot
Clinics and Research in Hepatology and Gastroenterology
|
November 13, 2012
Primary biliary cirrhosis and bile acids
Christophe Corpechot
Seminars in Liver Disease
|
February 13, 2016
Primary Biliary Cirrhosis Beyond Ursodeoxycholic Acid
Christophe Corpechot
Clinics in Liver Disease
|
November 24, 2015
Utility of Noninvasive Markers of Fibrosis in Cholestatic Liver Diseases
Christophe Corpechot
Clinics and Research in Hepatology and Gastroenterology
|
April 27, 2024
PPAR agonists in PBC: Where do we go from here? Or how to choose between the new and the old
Atsushi Tanaka, Christophe Corpechot
JHEP Reports : Innovation in Hepatology
|
February 11, 2020
New treatments/targets for primary biliary cholangitis
Christophe Corpechot, Raoul Poupon, Olivier Chazouillères
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 7, 2020
Definition and Management of Patients With Primary Biliary Cholangitis and an Incomplete Response to Therapy
Aldo J Montano-Loza, Christophe Corpechot
Journal of Hepatology
|
June 28, 2011
Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome
Christophe Corpechot, Olivier Chazouillères, Raoul Poupon
La Revue Du Praticien
|
February 11, 2022
[Primary biliary cholangitis]
Pierre-Antoine Soret, Olivier Chazouillères, Christophe Corpechot
Page
of 12